Oksenholt Capital Challenges Pershing Square's Discounted Freddie Mac Valuation

Oksenholt Capital Management released a valuation analysis contesting Pershing Square’s approach to valuing Freddie Mac (FMCC) at a materially lower earnings multiple than Fannie Mae (FNMA). The note broadly affirms both are “exceptional franchises,” but argues the valuation gap between Freddie and Fannie is narrower than Pershing’s framework implies. The impact is likely limited to positioning/valuation debate rather than immediate fundamentals.

Analysis

This is more about narrative control than near-term fundamentals. In housing-finance optics, the market is still paying for the probability-weighted path to recap/release; any argument that one GSE deserves a meaningfully lower multiple effectively narrows the set of plausible terminal outcomes and can compress the relative valuation gap rather than the absolute level. The first-order loser is not necessarily Freddie itself, but holders who need a clean, high-multiple symmetry story to justify aggressive upside underwriting.

The second-order effect is that relative-value capital will likely migrate to the name perceived as having the cleaner conversion path to distributable equity, while the other becomes a funding source for the pair. That matters because these securities trade more like policy options than operating businesses: a small change in credibility can drive a disproportionate move in the OTC common and preferreds, but only if it is reinforced by a concrete policy or court catalyst. Absent that, the market usually fades valuation commentary within days.

Risk-wise, the real catalyst horizon is months, not days. The thesis would be falsified if there is no follow-through in the spread between the two commons after the next policy headline, or if Treasury/FHFA language points back toward parity in any future recap framework. Conversely, if policymakers signal a capital plan that differentiates warrants, dividend capacity, or exit sequencing, the relative multiple debate becomes actionable and could persist for 6-18 months.

Contrarian view: the consensus may be over-reading the disagreement as a bearish signal for the whole trade. In practice, these debates often increase attention and expand the investor base for both names; the more important question is whether the market is pricing any realistic exit at all. If not, relative-multiple arguments matter less than regime-change probability, which remains the true driver of upside.

Key Decisions for Investors

• Do not chase PSHZF on this headline alone; treat it as noise unless the discussion is followed by a measurable change in the FMCC/FNMA spread over the next 1-2 weeks.
• Watch the FNMA/FMCC relative spread as a pair trade candidate: go long the cheaper security and short the richer one only if the discount moves beyond recent trading ranges and is confirmed by policy/news follow-through.
• If you already own housing-finance exposure, prefer a barbelled exposure to FNMA/FMCC over a single-name bet until there is clearer visibility on recapitalization sequencing; the key risk is policy-driven single-name underperformance.
• Set an alert for any FHFA/Treasury/court catalyst over the next 1-3 months; that is the only window where this valuation dispute can translate into persistent re-rating rather than a brief sentiment swing.
• Avoid using PSHZF as a proxy for this thesis unless the fund’s net exposure to housing-finance optionality is explicitly confirmed; otherwise the trade is likely too indirect to justify capital.